Huons Co Ltd
KOSDAQ:243070
Net Margin
Huons Co Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| KR |
H
|
Huons Co Ltd
KOSDAQ:243070
|
297.6B KRW |
5%
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
831.3B USD |
24%
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
-4%
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
373.7B USD |
24%
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.8T DKK |
35%
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
210.9B CHF |
14%
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
189.1B CHF |
23%
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
163.2B GBP |
13%
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
210.3B USD |
27%
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD |
-126%
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
116.7B EUR |
14%
|
Huons Co Ltd
Glance View
Huons Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2016-06-03.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Huons Co Ltd's most recent financial statements, the company has Net Margin of 5%.
You don't have any saved screeners yet